Author:
Johnson Katherine N. H.,Zaveri Nurulain,Gupta Kalpna
Reference61 articles.
1. Arpino G, Green SJ, Allred DC, Lew D, Martino S, Osborne CK, Elledge RM (2004) Her-2 amplification, her-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study. Clin Cancer Res 10:5670–5676. doi:10.1158/1078-0432.CCR-04-011010/17/5670 [pii]
2. Aylsworth CF, Hodson CA, Meites J (1979) Opiate antagonists can inhibit mammary tumor growth in rats. Proc Soc Exp Biol Med 161:18–20
3. Belcheva MM, Szucs M, Wang D, Sadee W, Coscia CJ (2001) Mu-opioid receptor-mediated erk activation involves calmodulin-dependent epidermal growth factor receptor transactivation. J Biol Chem 276:33847–33853
4. Berkson BM, Rubin DM, Berkson AJ (2009) Revisiting the ala/n (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases. Integr Cancer Ther 8:416–422. doi:8/4/416 [pii]10.1177/1534735409352082
5. Cadet P, Mantione K, Bilfinger TV, Stefano GB (2002) Morphine down regulates human vascular tissue estrogen receptor expression determined by real-time RT-PCR. Neuro Endocrinol Lett 23:95–100. doi:NEL230202A01 [pii]
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献